RedHill Biopharma (RDHL) EV to Revenue (2013 - 2026)

RedHill Biopharma (RDHL) EV to Revenue (2013 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to Revenue
1	Haleon	89.28 Bn	87.42 Bn	-	5.87
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	1.86
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	3.21
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	0.51
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	6.54
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	2.24
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	1.28
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	5.30
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	2.49
10	Vireo Growth	10.51 Bn	10.36 Bn	59.30 Mn	29.56

Download Data